These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 16825279
1. Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy. Imai H, Honda S, Nakanishi Y, Yamamoto H, Tsukahara Y, Negi A. Br J Ophthalmol; 2006 Dec; 90(12):1524-30. PubMed ID: 16825279 [Abstract] [Full Text] [Related]
3. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions. Tsuchiya D, Yamamoto T, Kawasaki R, Yamashita H. Retina; 2009 Dec; 29(7):960-5. PubMed ID: 19491727 [Abstract] [Full Text] [Related]
4. Photodynamic effects on retinal oxygen saturation, blood flow, and electrophysiological function in patients with neovascular age-related macular degeneration. Tsuchihashi T, Mori K, Peyman G, Shimada Y, Yoneya S. Retina; 2009 Dec; 29(10):1450-6. PubMed ID: 19816240 [Abstract] [Full Text] [Related]
9. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy. Lai TY, Lee GK, Luk FO, Lam DS. Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566 [Abstract] [Full Text] [Related]
10. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy. Yodoi Y, Tsujikawa A, Kameda T, Otani A, Tamura H, Mandai M, Yoshimura N. Am J Ophthalmol; 2007 Jun; 143(6):984-994. PubMed ID: 17336913 [Abstract] [Full Text] [Related]
11. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy. Gomi F, Sawa M, Wakabayashi T, Sasamoto Y, Suzuki M, Tsujikawa M. Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707 [Abstract] [Full Text] [Related]
12. Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy. Ishikawa K, Kondo M, Ito Y, Kikuchi M, Nishihara H, Piao CH, Sugita T, Terasaki H. Invest Ophthalmol Vis Sci; 2007 May; 48(5):2254-9. PubMed ID: 17460288 [Abstract] [Full Text] [Related]
14. Use of fluorescein and indocyanine green angiography in polypoidal choroidal vasculopathy patients following photodynamic therapy. Windisch R, Windisch BK, Cruess AF. Can J Ophthalmol; 2008 Dec; 43(6):678-82. PubMed ID: 19020634 [Abstract] [Full Text] [Related]
16. One-year results of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy. Song MH, Ryu HW, Roh YJ. Ophthalmologica; 2011 Dec; 226(3):119-26. PubMed ID: 21757883 [Abstract] [Full Text] [Related]
17. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Sasahara M, Tsujikawa A, Musashi K, Gotoh N, Otani A, Mandai M, Yoshimura N. Am J Ophthalmol; 2006 Oct; 142(4):601-7. PubMed ID: 17011852 [Abstract] [Full Text] [Related]